Ambea AB (publ) (STO:AMBEA)

Market Cap	9.92B
Revenue (ttm)	14.48B
Net Income (ttm)	625.00M
Shares Out	82.10M
EPS (ttm)	7.37
PE Ratio	16.39
Forward PE	12.19
Dividend	2.20 (1.79%)
Ex-Dividend Date	May 15, 2025

Volume	80,581
Average Volume	83,880
Open	122.50
Previous Close	123.10
Day's Range	120.00 - 122.50
52-Week Range	72.00 - 126.20
Beta	0.96
RSI	58.84
Earnings Date	Aug 19, 2025

About CTI BioPharma

Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities in Sweden, Norway, and Denmark. It operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The company offers social care services; schools for children and youth with neuropsychiatric disorders under the Nytida brand; nursing homes and home care services for elderly people under the Vardaga brand; and social care for adults, children, and youth, as well as personal assistance under the Stendi brand. It al...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1993
• Employees: 37,864
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: AMBEA

Financial Performance

In 2024, Ambea AB's revenue was 14.32 billion, an increase of 5.53% compared to the previous year's 13.57 billion. Earnings were 620.00 million, an increase of 36.26%.